Isolation and characterization of CD276+/HLA-E+ human subendocardial mesenchymal stem cells from chronic heart failure patients: Analysis of differentiative potential and immunomodulatory markers expression

Stem Cells and Development

Volumn 22, Issue 1, 2013, Pages 1-17

  Anzalone, Rita ^a   Corrao, Simona ^b   Lo Iacono, Melania ^b   Loria, Tiziana ^a   Corsello, Tiziana ^b   Cappello, Francesco ^a,b,c   Di Stefano, Antonino ^d   Giannuzzi, Pantaleo ^d   Zummo, Giovanni ^a   Farina, Felicia ^a   La Rocca, Giampiero ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto Euro Mediterraneo di Scienza e Tecnologia IEMEST   (Italy)

^c Department of Veterinary Medical Sciences   (Switzerland)

^d IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA E ANTIGEN; MYOSIN HEAVY CHAIN; PROTEIN; PROTEIN CD276; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CLONOGENESIS; CONTROLLED STUDY; ENDOCARDIUM; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOGENESIS; ANTIGENS, CD; B7 ANTIGENS; BIOLOGICAL MARKERS; CELL SEPARATION; CELLS, CULTURED; CHONDROGENESIS; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC FACTORS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 84873100461     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0402     Document Type: Article

References (104)

1. Friedenstein AJ, JF Gorskaya and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
3. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228. (Pubitemid 32295155)
4. Lindroos B, R Suuronen and S Miettinen. (2011). The potential of adipose stem cells in regenerative medicine. Stem Cell Rev 7:269-291.
5. Pevsner-Fischer M, S Levin and D Zipori. (2011). The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7:560-568.
6. Taghizadeh RR, KJ Cetrulo and CL Cetrulo. (2011). Wharton's jelly stem cells: future clinical applications. Placenta 32 (Suppl. 4):S311-S315.
7. Huang Y, O Parolini, G La Rocca and L Deng. (2012). Umbilical cord versus bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 21:2900-2903.
8. Anzalone R, M Lo Iacono, S Corrao, F Magno, T Loria, F Cappello, G Zummo, F Farina and G La Rocca. (2010). New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 19:423-438.
9. Anzalone R, M Lo Iacono, T Loria, A Di Stefano, P Giannuzzi, F Farina and G La Rocca. (2011a). Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev 7:342-363.
10. Prasanna SJ and JS Jahnavi. (2011). Wharton's jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: a closer look into their regenerative and immunomodulatory properties. Open Tissue Eng Regen Med J 4:28-38.
11. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, DJ Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315- 317.
12. Anzalone R, F Farina, G Zummo and G La Rocca. (2011). Recent patents and advances on isolation and cellular therapy applications of mesenchymal stem cells from human umbilical cord Wharton's jelly. Recent Pat Regen Med 1:216-227.
13. Kita K, GG Gauglitz, TT Phan, DN Herndon and MG Jeschke. (2010). Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilicalcord lining membrane. Stem Cells Dev 19:491-502.
14. Jeschke MG, GG Gauglitz, TT Phan, DN Herndon and K Kita. (2011). Umbilical cord lining membrane and Wharton's jelly-derived mesenchymal stem cells: the similarities and differences. Open Tissue Eng Regen Med J 4:21-27.
15. La Rocca G, R Anzalone, S Corrao, F Magno, T Loria, M Lo Iacono, A Di Stefano, P Giannuzzi, L Marasa, et al. (2009).Isolation and characterization of Oct-4 + /HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131:267-282.
16. Grajales L, J Garci'a, K Banach and DL Geenen. (2010). Delayed enrichment of mesenchymal cells promotes cardiaclineage and calcium transient development. J Mol Cell Cardiol 48:735-745.
17. Anzalone R, G La Rocca, A Di Stefano, F Magno, S Corrao, M Carbone, T Loria, M Lo Iacono, E Eleuteri, et al. (2009). Role of endothelial cell stress in the pathogenesis of chronic heart failure. Front Biosci 14:2238-2247.
18. Eleuteri E, A Di Stefano, FL Ricciardolo, F Magno, I Gnemmi,MColombo, R Anzalone, F Cappello, G La Rocca, et al. (2009). Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure. Int J Cardiol 135:386-390.
19. Chamuleau SAJ, KR Vrijsen, DG Rokosh, XL Tang, JJ Piek and R Bolli. (2009). Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J 17:199-207.
20. Trivedi P, N Tray, T Nguyen, N Nigam and GI Gallicano. (2010). Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later. Stem Cells Dev 19:1109-1120.
21. Eleuteri E, F Magno, I Gnemmi, M Carbone, M Colombo, G La Rocca, R Anzalone, F Tarro Genta, G Zummo, A Di Stefano and P Giannuzzi. (2009). Role of oxidative and nitrosative stress biomarkers in chronic heart failure. Front Biosci 14:2230-2237.
22. Forte E, I Chimenti, L Barile, R Gaetani, F Angelini, V Ionta, E Messina and A Giacomello. (2011). Cardiac cell therapy: the next (re)generation. Stem Cell Rev 7:1018-1030.
23. Karabekian Z, N Gillum Posnack and N Sarvazyan. (2011). Immunological barriers to stem-cell based cardiac repair. Stem Cell Rev 7:315-325.
24. Sui R, X Liao, X Zhou and Q Tan. (2011). The current status of engineering of myocardial tissue. Stem Cell Rev 7:172- 180.
25. Tamaki T, Y Uchiyama, Y Okada, K Tono, M Masuda, M Nitta, A Hoshi and A Akatsuka. (2010). Clonal differentiation of skeletal muscle-derived CD34-/Cd45- stem cells into cardiomyocytes in vivo. Stem Cells Dev 19:503-512.
26. Liu J, Z Zhang, Y Liu, C Guo, Y Gong, S Yang, M Ma, Z Li, W-Q Gao and Z He. (2012). Generation, characterization and potential therapeutic applications of cardiomyocytes from various stem cells. Stem Cells Dev DOI:10.1089/scd.2012. 0031.
27. Kodama H, T Inoue, R Watanabe, H Yasuoka, Y Kawakami, S Ogawa, Y Ikeda, K Mikoshiba and M Kuwana. (2006). Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14 + monocytes. Stem Cells Dev 14:676-686.
28. Armin án A, C Gandía, M Bartual, JM García-Verdugo, E Lledó, V Mirabet, M Llop, J Barea, JA Montero and P Sepu ́ lveda. (2009). Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev 18:907-918.
29. Roura S, J Farre', L Hove-Madsen, C Prat-Vidal, C Soler- Botija, C Galvez-Monton, M Vilalta and A Bayes-Genis. (2010). Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells. Basic Res Cardiol 105:419-430.
30. Semenov OV and C Breymann. (2011). Mesenchymal stem cells derived from Wharton's jelly and their potential for cardio-vascular tissue engineering. Open Tissue Eng Regen Med J 4:64-71.
31. Hollweck T, I Hartmann, M Eblenkamp, E Wintermantel, B Reichart, P U? berfuhr and G Eissner. (2011). Cardiac differentiation of human Wharton's jelly stem cells - experimental comparison of protocols. Open Tissue Eng Regen Med J 4:95-102.
32. Wu J, J Li, N Zhang and C Zhang. (2011). Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol106:317-324.
33. Collins MC, JL Moore Jr, BJ Burrows, AP Kypson and BJ Muller-Borer. (2012). Early cell loss associated with mesenchymal stem cell cardiomyoplasty. Open Tissue Eng Regen Med J 5:17-24.
34. La Rocca G. (2011). Connecting the dots: the promises of Wharton's jelly mesenchymal stem cells for tissue repair and regeneration. Open Tissue Eng Regen Med J 4:3-5.
35. Miyamoto S, N Kawaguchi, GM Ellison, R Matsuoka, T Shin'oka and H Kurosawa. (2010). Characterization of long-term cultured c-kit + cardiac stem cells derived from adult rat hearts. Stem cell Dev 19:105-116.
36. Sandstedt J, M Jonsson, A Lindahl, A Jeppsson and J Asp. (2010). C-kit + CD45- cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res Cardiol 105:545-556.
37. Sandstedt J, M Jonsson, K Kajic, M Sandstedt, A Lindahl, G Dellgren, A Jeppsson and J Asp. (2012). Left atrium of the human heart contains a population of side population cells. Basic Res Cardiol 107:255.
38. La Rocca G, A Di Stefano, E Eleuteri, R Anzalone, F Magno, S Corrao, T Loria, A Martorana, C Di Gangi, M Colombo, et al. (2009). Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure. Basic Res Cardiol 104:307-320.
39. La Rocca G, R Anzalone, F Magno, F Farina, F Cappello and G Zummo. (2007). Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Respir Res 8:23.
40. Spencer WE and MJ Christensen. (1999). Multiplex relative RT-PCR method for verification of differential gene expression. Biotechniques 27:1044-1052. (Pubitemid 29529630)
41. Weiss ML, S Medicetty, AR Bledsoe, RS Rachakatla, M Choi, S Merchav, Y Luo, MS Rao, G Velagaleti and D Troyer. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24:781-792. (Pubitemid 44464783)
42. Petit B, K Masuda, A D'Souza, L Otten, D Pietryla, DJ Hatrmann, NP Morris, D Uebelhart, TM Schmid and EJ Thonar. (1996). Characterization of crosslinked collagens synthesized by mature articular chondrocytes cultured in alginate beads: comparison of two distinct matrix compartments.Exp Cell Res 225:151-161. (Pubitemid 26158465)
43. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295. (Pubitemid 35471185)
44. Wei P, L Li, H Qi, HX Zhou, CY Deng and FR Li. (2012). Reversible immortalization of Nestin-positive precursor cells from pancreas and differentiation into insulinsecreting cells. Biochem Biophys Res Commun 418:330-335.
45. Mitchell KE, ML Weiss, BM Mitchell, P Martin, D Davis, L Morales, B Helwig, M Beerenstrauch, K Abou-Easa, et al. (2003). Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21:50-60. (Pubitemid 36120365)
46. Francis R, X Xu, H Park, CJ Wei, S Chang, B Chatterjee and C Lo. (2011). Connexin43 modulates cell polarity and directional cell migration by regulating microtubule dynamics. PLoS One 6:e26379.
47. Hesketh GG, MH Shah, VL Halperin, CA Cooke, FG Akar, TE Yen, DA Kass, CE Machamer, JE Van Eyk and GF Tomaselli.(2010). Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res 106:1153-1163.
48. De Lanerolle P and L Serebryannyy. (2011). Nuclear actin and myosins: life without filaments. Nat Cell Biol 13:1282- 1288.
49. Peterkin T, A Gibson, M Loose and R Patient. (2005). The roles of GATA-4, - 5 and - 6 in vertebrate heart development. Semin Cell Dev Biol 16:83-94. (Pubitemid 40126879)
50. Micklem K, E Rigney, J Cordell, D Simmons, P Stross, H Turley, B Seed and D Mason. (1989). A human macrophage- associated antigen (CD68) detected by six different monoclonal antibodies. Br J Haematol 73:6-11. (Pubitemid 19237726)
51. Gottfried E, LA Kunz-Schughart, A Weber, M Rehli, A Peuker, A Mu? ller, M Kastenberger, G Brockhoff, R Andreesen and M Kreutz. (2008). Expression of CD68 in nonmyeloid cell types. Scand J Immunol 67:453-463. (Pubitemid 351519391)
52. La Rocca G, R Anzalone and F Farina. (2009). The expression of CD68 in human umbilical cord mesenchymal stem cells: new evidences of presence in non-myeloid cell types. Scand J Immunol 70:161-162.
53. Hunt JS, MG Petroff, RH McIntire and C Ober. (2005). HLA-G and immune tolerance in pregnancy. FASEB J 19:681-693. (Pubitemid 40617373)
54. Coupel S, A Moreau, M Hamidou, V Horejsi, JP Soulillou and B Charreau. (2007). Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109:2806-2814. (Pubitemid 46482075)
55. Iwaszko M and K Bogunia-Kubik. (2011). Clinical significance of the HLA-E and CD94/NKG2 interaction. Arch Immunol Ther Exp 59:353-367.
56. Leitner J, C Klauser, WF Pickl, J Sto?ckl, O Majdic, AF Bardet, DP Kreil, C Dong, T Yamazaki, et al. (2009). B7-H3 is a potentinhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction. Eur J Immunol 39:1754-1764.
57. Loos M, DM Hedderich, H Friess and J Kleeff. (2010). B7-h3 and its role in antitumor immunity. Clin Dev Immunol 2010:683875.
58. Al-Nbaheen M, R Vishnubalaji, D Ali, A Bouslimi, F Al- Jassir, M Megges, A Prigione, J Adjaye, M Kassem and A Aldahmash. (2012). Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev DOI:10.1007/s12015-012-9365-8.
59. Tyndall A, UA Walker, A Cope, F Dazzi, C De Bari, W Fibbe, S Guiducci, S Jones, C Jorgensen, et al. (2007). Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 9:301.
60. Juneja HS, S Rajaraman, RE Gay, S Gay and FC Schmalsteig. (1992). Characterization of heterotypic adherence between transformed human lymphoblastic cells and marrow stromal cells: VCAM-1 is a ligand for one of the leukemia cell adhesion proteins. Exp Hematol 20:1263- 1270.
61. Karahuseyinoglu S, O Cinar, E Kilic, F Kara, GG Akay, DO Demiralp, A Tukun, D Uckan and A Can. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25:319-331. (Pubitemid 46232786)
62. Ehninger A and A Trumpp. (2011). The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208:421-428.
63. Kirino T,MWBrightman, WH Oertel, DE Schmechel and PJ Marangos. (1983). Neuron-specific enolase as an index of neuronal regeneration and reinnervation. J Neurosci 3: 915-923. (Pubitemid 13081962)
64. Romanov YA, VA Svintsitskaya and VN Smirnov. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110. (Pubitemid 36120371)
65. Tondreau T, L Lagneaux, M Dejeneffe, M Massy, C Mortier, A Del forge and D Bron. (2004). Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 82:319- 326. (Pubitemid 41702124)
66. Sansom DM, CN Manzotti and Y Zheng. (2003). What's the difference between CD80 and CD86? Trends Immunol 24:313-318. (Pubitemid 36694881)
67. Zhu X-Y, Y-H Zhou, M-Y Wang, L-P Jin, M-M Yuan and DJ Li. (2005). Blockade of CD86 signaling facilitates a Th2 bias at the maternal-fetal interface and expands peripheral CD4+ CD25 + regulatory T cells to rescue abortion-prone fetuses. Biol Reprod 72:338-345. (Pubitemid 40129709)
68. Moscoso J, JI Serrano-Vela, R Pacheco and A Arnaiz- Villena. (2006). HLA-G, -E and -F: allelism, function and evolution. Transpl Immunol 17:61-64. (Pubitemid 44828794)
69. Boyle LH, AK Gillingham, S Munro and J Trowsdale. (2006). Selective export of HLA-F by its cytoplasmic tail. J Immunol 176:6464-6472. (Pubitemid 43787828)
70. Goodridge JP, A Burian, N Lee and DE Geraghty. (2010). HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol 184:6199- 6208.
71. Agullo-Pascual E and M Delmar. (2012). The noncanonical functions of Cx43 in the heart. J Membr Biol DOI:10.1007/ s00232-012-9466-y.
72. Coppen SR, E Dupont, S Rothery and NJ Severs. (1998). Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 82:232-243. (Pubitemid 28080106)
73. Khattar P, FW Friedrich, G Bonne, L Carrier, T Eschenhagen, SM Evans, K Schwartz, MY Fiszman and J-T Vilquin. (2011). Distinction between two populations of islet-1 positive cells in hearts of different murine strains. Stem Cells Dev 20:1043-1052.
74. Eyre D. (2002). Collagen of articular cartilage. Arthritis Res 4:30-35. (Pubitemid 34100487)
75. Lo Iacono M, R Anzalone, S Corrao, M Giuffre, A Di Stefano, P Giannuzzi, F Cappello, F Farina and G La Rocca. (2011). Perinatal and Wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies. Open Tissue Eng Regen Med J 4: 72-81.
76. Rota M, ME Padin-Iruegas, Y Misao, A De Angelis, S Maestroni, J Ferreira-Martins, E Fiumana, R Rastaldo, ML Arcarese, et al. (2008). Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103:107-116.
77. Mishra R, K Vijayan, EJ Colletti, DA Harrington, TS Matthiesen, D Simpson, SK Goh, BL Walker, G Almeida- Porada, et al. (2011). Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 123:364-373.
78. Lushaj EB, E Anstadt, R Haworth, D Roenneburg, J Kim, P Hematti and T Kohmoto. (2011). Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy 4:400-406.
79. Stanton T and TH Marwick. (2010). Assessment of subendocardial structure and function. J Am Coll Cardiol Img 3:867-875.
80. Hung CT and RL Mauck. (2004). Biological assays: cellular level. In: Biomedical Technology and Devices Handbook. Moore JE, G Zouridakis, eds. CRC Press, London, pp 15:1-15:39.
81. Balamurugan AN, J He, F Guo, DB Stolz, S Bertera, X Geng, X Ge, M Trucco and R Bottino. (2005). Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation. Am J Transplant 5:2671-2681.
82. Asumda FZ and PB Chase. (2012). Nuclear cardiac troponin and tropomyosin are expressed early in cardiac differentiation of rat mesenchymal stem cells. Differentiation 83:106-115.
83. Lee N, M Llano, M Carretero, A Ishitani, F Navarro, M Ló pez-Botet and DE Geraghty. (1998). HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A. Proc Natl Acad Sci USA 95:5199-5204. (Pubitemid 28208575)
84. Choudhury SR and LA Knapp. (2001). Human reproductive failure II: immunogenetic and interacting factors. Hum Reprod Update 7:135-160. (Pubitemid 32208495)
85. Ishitani A, N Sageshima, N Lee, N Dorofeeva, K Hatake, H Marquardt and DE Geraghty. (2003). Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171:1376-1384. (Pubitemid 36900070)
86. Ishitani A, N Sageshima and K Hatake. (2006). The involvement of HLA-E and -F in pregnancy. J Reprod Immunol 69:101-113.
87. Shobu T, N Sageshima, H Tokui, M Omura, K Saito, Y Nagatsuka, M Nakanishi, Y Hayashi, K Hatake and A Ishitani. (2006). The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. J Reprod Immunol 72:18-32. (Pubitemid 44692306)
88. Corrao S, C Campanella, R Anzalone, F Farina, G Zummo, E Conway de Macario, AJ Macario, F Cappello and G La Rocca. (2010). Human Hsp10 and early pregnancy factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives. Life Sci 86:145-152.
89. Parham P, PJ Norman,LAbi-Rached andLAGuethlein. (2012). Human-specific evolution of killer cell immunoglobulinlike receptor recognition of major histocompatibility complex class I molecule. Philos Trans R Soc Lond B Biol Sci 367:800-811.
90. Smith M, JG Bittner 4th, S White, D Smith and A Horuzsko. (2008). HLA-G-treated tolerogenic dendritic cells induce tolerogenic potential by increasing expression of B7-1 (CD80) molecules. Transplant Proc 40:1598-1603. (Pubitemid 351853137)
91. Kurtz J, F Raval, C Vallot, J Der and M Sykes. (2009). CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance. Blood 113:3475-3484.
92. Zhang Y, EM Kanter and KA Yamada. (2010). Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovasc Pathol 19:e233-e240.
93. Latif N, P Sarathchandra, PM Taylor, J Antoniw, N Brand and MH Yacoub. (2006). Characterization of molecules mediating cell-cell communication in human cardiac valve interstitial cells. Cell Biochem Biophys 45:255-264. (Pubitemid 44127942)
94. Brewer AC, A Alexandrovich, CH Mjiaatvedt, AM Shah, RK Patient and JA Pizzey. (2005). GATA factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis. Stem Cells Dev 14:425-439. (Pubitemid 41244834)
95. Song K, YJ Nam, X Luo, X Qi, W Tan, GN Huang, A Acharya, CL Smith, MD Tallquist, et al. (2012). Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485:599-604.
96. Madonna R, R De Caterina, JT Willerson and YJ Geng. (2011). Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur Heart J 32:1190-1196.
97. Yano M. (2008). Ryanodine receptor as a new therapeutic target of heart failure and lethal arrhythmia. Circ J 72:509-514. (Pubitemid 351679398)
98. Turillazzi E, G La Rocca, R Anzalone, S Corrao, M Neri, C Pomara, I Riezzo, SB Karch and V Fineschi. (2008). Heterozygous nonsense SCN5A mutation W822 explains a simultaneous sudden infant death syndrome. Virchows Arch 453:209-216.
99. Turillazzi E, C Pomara, G La Rocca, M Neri, I Riezzo, SB Karch, R Anzalone, M Lo Iacono and V Fineschi. (2009). Immunohistochemical marker for Na+ CP type Valpha (C- 20) and heterozygous nonsense SCN5A mutation W822 in a sudden cardiac death induced by mild anaphylactic reaction. Appl Immunohistochem Mol Morphol 17: 357-362.
100. Li Y, G Wu, Q Tang, C Huang, H Jiang, L Shi, X Tu, J Huang, X Zhu and H Wang. (2011). Slow cardiac myosin regulatory light chain 2 (MYL2) was down-expressed in chronic heart failure patients. Clin Cardiol 34:30-34.
101. Freiburg A and M Gautel. (1996). A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 235:317-323.
102. Flashman E, C Redwood, J Moolman-Smook and H Watkins. (2004). Cardiac myosin binding protein C: its role in physiology and disease. Circ Res 94:1279-1289. (Pubitemid 38724473)
103. Sehnert AJ, A Huq, BM Weinstein, C Walker, M Fishman and DY Stainier. (2002). Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 31:106-110.
104. Zhao Y, XM Meng, YJ Wei, XW Zhao, DQ Liu, HQ Cao, CC Liew and JF Ding. (2003). Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J Mol Med (Berl) 81:297-304. (Pubitemid 36718326)